Zepbound (Tirzepatide) Vomiting: Supplements With the Best Evidence
Evidence-based supplements to reduce vomiting on Zepbound (tirzepatide), with clinical trial data, dosing, and a decision framework.
Evidence-based supplements to reduce vomiting on Zepbound (tirzepatide), with clinical trial data, dosing, and a decision framework.
Evidence-based sildenafil dosing for patients aged 65+, including starting doses, titration steps, drug interaction risks, renal and hepatic adjustments, and deprescribing guidance prepared by the HealthRX.com Editorial Team.
A clinician-oriented review of sildenafil use in autoimmune conditions: pharmacology, drug interaction risk, dosing caution points, and the evidence boundaries around Raynaud phenomenon, connective-tissue-disease PAH, and proposed anti-inflammatory effects.
A physician-level review of the evidence on sildenafil and cancer risk, covering melanoma, prostate, and other signals, with clinical guidance on who should be monitored and why.
A guide to acne vulgaris, male and female pattern hair loss, telogen effluvium, and alopecia areata. Covers FDA-approved drugs, off-label options, evidence quality, and when to seek in-person care.
A guide to adolescent acne covering pathophysiology, evidence-based treatments (topical and systemic), hormonal therapies, hair loss in teens, pregnancy-safe options, and postmenopausal skin changes.
Evidence-based answers on collagen supplements for skin, oral and topical minoxidil for women, finasteride and PFS risk, and the real Accutane timeline. Written by the HealthRX.com medical team.
How to distinguish hirsutism, pattern hair loss, diffuse shedding and alopecia areata, with diagnosis-specific tests, treatments and follow-up.
4% hydroquinone cream lightens skin in 8 to 12 weeks. See dosing, the 3 to 6 month use limit, and how it compares to tretinoin and adapalene.
A guide to psoriasis covering pathophysiology, FDA-approved systemic and biologic therapies, and how psoriasis overlaps with scalp hair loss conditions including telogen effluvium and alopecia areata.
A guide to rosacea subtypes, male and female pattern hair loss, telogen effluvium, and alopecia areata. Includes FDA-approved treatments, dosing details, and clinical trial data.
A guide to prescription and evidence-based treatments for skin aging, hair loss, and medical aesthetics, including tretinoin, minoxidil, GHK-Cu peptides, PRP, and GLP-1 effects on skin quality.
Topical minoxidil is OTC for hair loss; needs daily use for 16+ weeks and ongoing use to keep results. See dosing, results, and how it compares to other topical Rx.
A detailed guide to CareFirst BlueCross BlueShield coverage for Dupixent (dupilumab), including prior authorization requirements, step therapy, appeal rights, and cost-saving options for atopic dermatitis, asthma, and other FDA-approved indications.
Find out whether Regence BlueCross BlueShield covers Dupixent (dupilumab) for atopic dermatitis, asthma, and other approved indications, including prior authorization steps, cost-sharing, and appeal strategies.
A step-by-step guide to layering skincare products in midlife, covering morning and evening routines, hormone-driven skin changes, and evidence-based ingredient choices.
A clinical deep-dive into whether topically applied estriol absorbs enough to raise serum estrogen levels, affect the endometrium, or require progestogen co-administration. Evidence-based.
Adults start at 25 to 50 mg daily, titrating to 50 to 100 mg for acne control. Max studied dose is 200 mg/day. Includes potassium monitoring schedule.
A clinical guide to spironolactone monitoring for adults aged 30 to 49 using it for hormonal acne or hirsutism, with context on cardiac and blood pressure uses. Covers lab schedules, potassium risks, blood pressure, drug interactions, and pregnancy precautions.
Evidence-based spironolactone dosing for adults aged 50, 64 treating hormonal acne, hirsutism, or heart failure. Covers starting doses, titration, perimenopause overlap, potassium monitoring, and drug interactions.
Evidence-based overview of spironolactone in children under 12: FDA-approved pediatric indications, weight-based dosing, potassium and renal monitoring, blood pressure and growth surveillance, and where the acne indication has no pediatric evidence base.
A week-by-week first-month spironolactone plan for acne, with practical tracking, dose review, testing guidance and results from SAFA and Mayo Clinic.
A clinician-level review of spironolactone's effects on the kidneys: when it shields renal function, when it harms it, and how to monitor patients safely across every indication.
A clinical review of the glutathione, alprostadil interaction: pharmacokinetics, oxidative-stress biology, safety signals, dosing timing, and monitoring for men using Caverject or MUSE.
A guide to the NAC and alprostadil interaction, covering pharmacokinetics, pharmacodynamics, dosing windows, monitoring, and safety for men using Caverject or MUSE.
A guide to the turmeric and alprostadil interaction: mechanism, bleeding risk, dose considerations, and monitoring advice for men using Caverject or MUSE.
A guide to combining lion's mane mushroom with AndroGel (testosterone gel), covering pharmacokinetic interactions, blood-thinning risk, NGF effects, monitoring, and practical dosing guidance.
A guide covering the AndroGel-magnesium interaction, mechanisms, dosing guidance, monitoring labs, and safety for men on testosterone gel therapy.
A guide to combining omega-3 fatty acids (EPA/DHA) with AndroGel testosterone gel, covering pharmacodynamic interactions, antiplatelet concerns, triglyceride effects, monitoring, and practical dosing guidance.
A clinical review of vitamin B6 and AOD-9604 (HGH fragment 176-191) co-administration: interaction type, safety evidence, dosing considerations, and monitoring guidance from the HealthRX.com medical team.
A guide to the BPC-157 and calcium interaction: pharmacokinetics, dosing windows, monitoring, and what current research actually shows.
A guide to the pharmacokinetic and pharmacodynamic considerations of combining BPC-157 pentadecapeptide with green tea extract or EGCG, including hepatotoxicity risk, dose-separation windows, and monitoring recommendations.
A guide to combining L-theanine with BPC-157 pentadecapeptide: mechanisms, pharmacokinetics, safety evidence, dosing windows, and monitoring recommendations.
A guide to combining magnesium supplementation with BPC-157 pentadecapeptide. Covers pharmacokinetic and pharmacodynamic interactions, timing, dosing, and monitoring recommendations.
A guide to combining omega-3 fatty acids (EPA/DHA) with BPC-157 peptide therapy, covering pharmacodynamic interactions, bleeding risk, dosing timing, and monitoring protocols.
A guide covering the pharmacodynamic and pharmacokinetic interactions between BPC-157 pentadecapeptide and reishi mushroom, including dosing windows, bleeding risk, immune effects, and monitoring recommendations.
A guide covering the pharmacokinetic and pharmacodynamic interactions between BPC-157 pentadecapeptide and resveratrol, including dosing, timing, monitoring, and safety considerations.
A guide to combining BPC-157 pentadecapeptide with vitamin D: mechanism, interaction type, dosing, monitoring, and safety considerations backed by primary literature.
A clinically grounded review of the saw palmetto and Vyleesi (bremelanotide) combination: what the pharmacology shows, what risks exist, and what to tell your prescriber before mixing them.
A guide to the quercetin, tadalafil interaction: CYP3A4 pharmacokinetics, hypotension risk, safe dosing windows, and what to tell your prescriber before combining both.
St John's Wort is a well-known CYP3A4 enzyme inducer, and tadalafil (Cialis) is cleared mainly through that enzyme. Here is what is established, what is extrapolated, and what still needs verification before you or your prescriber act on it.
A guide covering the pharmacodynamic interactions between ashwagandha (KSM-66 / Sensoril) and CJC-1295 modified GRF, including cortisol modulation, GH axis effects, thyroid impact, and practical dosing guidance.
A clinical review of the pharmacodynamic and pharmacokinetic interactions between ginseng and CJC-1295 modified GRF, including glucose effects, anticoagulant potentiation, monitoring parameters, and dosing guidance from a board-certified medical team.
A guide to the pharmacokinetic and pharmacodynamic interactions between CJC-1295 (modified GRF) and turmeric / curcumin, including dosing windows, monitoring, and safety evidence.
A guide on combining vitamin B12 with Farxiga (dapagliflozin). Learn what the evidence says about interactions, who is at risk, how to dose, and when to test your B12 levels.
A guide on combining omega-3 fish oil (EPA/DHA) with Trulicity (dulaglutide): pharmacodynamic interactions, triglyceride effects, bleeding risk, monitoring, and practical dosing advice.
A guide covering whether vitamin B6 is safe to take with Trulicity (dulaglutide), any known interactions, dose considerations, and monitoring recommendations for people with type 2 diabetes.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between berberine and dutasteride (Avodart), including CYP3A4 inhibition data, monitoring guidance, and a practical decision framework for men on BPH or hair-loss therapy.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between green tea extract / EGCG and dutasteride (Avodart), including hepatotoxicity risk, CYP3A4 considerations, dosing guidance, and monitoring recommendations.
A guide to the dutasteride-magnesium interaction: pharmacokinetics, safety, dose timing, and monitoring for men on Avodart for BPH or hair loss.
A board-reviewed guide to taking vitamin B6 with Avodart (dutasteride): interaction mechanisms, safe dose ranges, monitoring advice, and when to call your prescriber.
A guide to the ashwagandha and enclomiphene citrate combination: pharmacodynamic interactions, cortisol and testosterone overlap, thyroid effects, monitoring protocols, and practical dosing guidance.
A guide to combining creatine monohydrate with enclomiphene citrate: pharmacokinetic interactions, creatinine monitoring, dosing strategy, and safety evidence.
A guide to combining glycine supplementation with enclomiphene citrate: interaction type, safety profile, dosing, and monitoring recommendations.
A clinical review of the quercetin, enclomiphene citrate interaction, covering CYP3A4 pharmacokinetics, antihistamine overlap, dose-separation strategies, and monitoring guidance for men on TRT-alternative therapy.
St. John's Wort is a documented CYP3A4 and P-glycoprotein inducer. Enclomiphene citrate is metabolized in part by CYP450 enzymes, so combining the two is a plausible but not directly studied interaction risk. Here is what is established, what is extrapolated, and what to verify with a prescriber.
A guide to taking vitamin B12 alongside enclomiphene citrate for secondary hypogonadism: interaction mechanisms, safety data, monitoring labs, and dosing guidance.
A guide to combining vitamin B6 and enclomiphene citrate: interaction mechanisms, safe dose ranges, monitoring recommendations, and when to pause supplementation.
A clinical review of the safety, pharmacokinetics, and monitoring considerations for combining vitamin D supplementation with enclomiphene citrate in men with secondary hypogonadism.
A guide to combining 5-HTP and Epitalon (epitalon tetrapeptide): interaction mechanisms, serotonin syndrome risk, dosing windows, and monitoring recommendations.